The Further Adventures of Newborn Screening for Biotinidase Deficiency: Where It Is at and What We Still Need to Know
Biotinidase deficiency is an inherited metabolic disorder that, if untreated, can result in neurological and cutaneous symptoms. If treated with the vitamin biotin, individuals with the disorder can markedly improve, but still may have some irreversible problems if therapy is delayed. If treated at...
Main Author: | Barry Wolf |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2016-10-01
|
Series: | International Journal of Neonatal Screening |
Subjects: | |
Online Access: | http://www.mdpi.com/2409-515X/2/4/9 |
Similar Items
-
Outcomes of oral biotin treatment in patients with biotinidase deficiency — Twenty years follow-up
by: Edyta Szymańska, et al.
Published: (2015-12-01) -
Biotinidase Deficiency: Prevalence, Impact And Management Strategies
by: Canda E, et al.
Published: (2020-05-01) -
Newborn screening for biotinidase deficiency in Brazil: biochemical and molecular characterizations
by: E. C. Neto, et al.
Published: (2004-03-01) -
Newborn Screening for Biotinidase Deficiency. The Experience of a Regional Center in Italy
by: Alice Maguolo, et al.
Published: (2021-05-01) -
Epilepsy in biotinidase deficiency
by: A. G. Malov, et al.
Published: (2016-03-01)